Rebus Holdings Inc (NSPX)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Rebus Holdings Inc. Defies Odds: From $-1.365 Mil Net Deficit to $0 Mil Revenue in Q2 2023
Rebus Holdings Inc Emerges with Improved Net Shortfall Amidst Challenging Market Conditions
Substantial improvement in Revenues by the company all along the October to December 31 2022 span
The Losses have enlarged further at the company in fiscal interval ending September 30 2016